À retenir
In US veterans, all-cause mortality was 24.7% in type 1 narcolepsy and 29.1% in other narcolepsy, versus 15.0% in general sleep clinic patients (adjusted odds ratio 1.64 and 2.40). The groups differed in mean age and the data come from one health system, so the result may not carry over to other populations.
Study design
Étude de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Earlier work suggested people with narcolepsy die earlier than the general population, but the evidence is disputed and few studies compare them with other people seen in sleep clinics. The authors compared deaths, hospital stays and emergency or urgent care visits in veterans with narcolepsy against a general sleep clinic group.
Population et méthode
Retrospective cohort study of nationwide Veterans Health Administration data from October 1999 through March 2025, using ICD-9/10 codes. Type 1 narcolepsy (NT1) required at least two NT1 codes. Two comparison groups were matched on age at index date, sex, race/ethnicity and diagnosis year: general sleep clinic patients without central hypersomnia codes (matched 1:3) and an 'other narcolepsy' group with narcolepsy codes but no NT1-specific code (matched 1:1). The primary outcome was all-cause mortality; secondary outcomes were hospitalization and emergency department/urgent care visits. Multivariable logistic regression adjusted for age, body mass index and Charlson Comorbidity Index.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The study included 4161 NT1, 4161 other narcolepsy and 12,843 general sleep clinic participants. Mean age was 48.0, 47.6 and 43.8 years, respectively.
- 2Deaths were more frequent in narcolepsy: 24.7% in NT1, 29.1% in other narcolepsy and 15.0% in the general sleep clinic group.
- 3After adjustment, the odds of death were higher than in the general sleep clinic group for NT1 (adjusted odds ratio 1.64, 95% CI 1.47-1.82) and for other narcolepsy (adjusted odds ratio 2.40, 95% CI 2.16-2.66).
- 4Hospitalization was higher only in NT1 (adjusted odds ratio 1.13, 95% CI 1.05-1.22).
Limites et incertitude
- 1Participants were veterans referred for sleep evaluation, and the authors say generalizability to non-VA populations is uncertain.
- 2Diagnoses rely on billing codes, and the 'other narcolepsy' group is defined only by lacking NT1-specific codes.
- 3The groups differed in mean age despite matching, and the abstract reports no cause-specific deaths or modifiable risk factors.
- 4This reading is based on the abstract only.
Mise en perspective
People with narcolepsy may face higher mortality than other sleep clinic patients, which supports regular follow-up of overall health. The study cannot say why the deaths occurred or whether any change in care would lower the risk. Questions about narcolepsy care belong with a sleep clinician.
Vos données
Narcolepsy is diagnosed with clinical sleep testing, not wearable data, so there is nothing here to track yourself. If you have a diagnosis, a sleep diary or consistent device-based sleep timing can help you describe daytime sleepiness at appointments.
Comprendre ce type de preuve
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
Prior research shows increased mortality in patients with narcolepsy compared to the general population; overall, the evidence remains highly controversial and comparative data with general sleep clinic populations remains limited.
Objective
We examined mortality and healthcare utilization among patients with narcolepsy compared to a general sleep clinic (GSC) cohort in the Veterans Affairs (VA) health system.
Design
Retrospective cohort study.
Setting
Nationwide Veterans Health Administration (VHA) data from October 1999 through March 2025.
Participants
The study used relevant ICD-9/10 codes. We defined narcolepsy 1 (NT1) as patients with at least two NT1 ICD-9/10 codes. We constructed two propensity-matched (on age at index date, sex, race/ethnicity, and diagnosis year) comparison groups: (i) General Sleep Clinic (GSC; with no central disorders of hypersomnia ICD codes), matched 1:3 and (ii) other narcolepsy (ON) group as patients with at least two narcolepsy ICD-9/10 codes but no NT1-specific codes, matched 1:1 to NT1 group.
Main outcomes and measures
The primary outcome was all-cause mortality. Secondary outcomes included all-cause hospitalization and emergency department/urgent care (ED/UC) visits. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression in the propensity score-matched cohorts, with GSC as the reference group and adjustment for age, body mass index, and Charlson Comorbidity Index.
Results
The cohort included 4161 NT1, 4161 ON, and 12,843 GSC participants. The mean age differed in the groups (48.0, 47.6, and 43.8 years for NT1, ON, and GSC, respectively). All-cause mortality was more frequent in NT1 and ON compared to GSC (24.7%, 29.1%, and 15.0% in NT1, ON, and GSC, respectively). Compared with GSC, aOR was higher in NT1 (aOR 1.64, 95% CI 1.47-1.82) and ON (aOR 2.40, 95% CI 2.16-2.66). In contrast, increased aOR of all-cause hospitalization was observed only in NT1 (aOR 1.13, 95% CI 1.05-1.22) compared to GSC.
Conclusions and relevance
Among veterans referred for sleep evaluation, adjusted OR of all-cause mortality was higher in narcolepsy patients compared to patients with other sleep disorders. The generalizability to non-VA populations remains uncertain. Future studies should identify cause-specific mortality and modifiable risk factors for prevention.
Key points
Question: In veterans referred for sleep evaluation, is narcolepsy associated with higher all-cause mortality than general sleep clinic patients?
Findings
In a retrospective propensity-matched cohort study of VA data (1999-2025) including 4161 NT1, 4161 other narcolepsy, and 12,843 general sleep clinic participants, mortality was 24.7%, 29.1%, and 15.0%; adjusted odds of mortality were significantly higher for NT1 (aOR 1.64) and other narcolepsy (aOR 2.40) vs. general sleep clinic. Meaning: These findings suggest elevated mortality risk in narcolepsy, highlighting the need for targeted prevention and risk-management strategies.
Sources et attribution
Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study.
Sharafkhaneh A, Dauvilliers Y, BaHammam AS, Azarian M, Thorpy M, Han F, Senel GB, Aksu M, Razjouyan J.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026-05-04
DOI: 10.1007/s44470-026-00078-8 ↗PubMed · 42082712 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

